AI Healthcare Market Forecast Projects 24x Growth by 2035
A new market report claims AI in healthcare will balloon from $38 billion to $928 billion in a decade — a 24x return that should make anyone reach for the methodology footnotes before the press release.
Explanation
The headline number is eye-catching: the AI-in-healthcare market supposedly grows at 37.66% per year (CAGR — compound annual growth rate, meaning the average yearly growth if you smooth out the curve) through 2035, ending up just shy of $1 trillion. For context, that would make it one of the fastest-growing large markets on record.
The problem is that this kind of forecast is a genre, not a science. Market research firms routinely publish 10-year projections with suspiciously round CAGRs and little transparency about what's actually being counted. Does "AI in healthcare" include every SaaS tool with a regression model? Every hospital chatbot? The scope definition does most of the heavy lifting in these numbers, and it's rarely disclosed upfront.
What's real: AI adoption in radiology, drug discovery, clinical documentation, and revenue cycle management is genuinely accelerating. Companies like Google, Microsoft, and a wave of well-funded startups are landing real contracts with real health systems. Regulatory pathways for AI-based medical devices are maturing in the US and EU. The directional signal — growth — is credible.
What's hype: the precision. A 37.66% CAGR over 10 years assumes no major regulatory crackdowns, no high-profile AI diagnostic failures that spook hospital procurement, no reimbursement stalemates, and sustained capital availability. Each of those is a live risk.
The practical takeaway for anyone allocating attention or capital: the market is growing fast, but the $928 billion figure is a ceiling built on best-case assumptions stacked on top of each other. Watch actual hospital IT budget shifts and FDA clearance rates — those are the real leading indicators, not a decade-out projection from a firm selling the report for $4,500.
The forecast — $37.98B in 2025 to $928.18B by 2035 at a 37.66% CAGR — sits at the aggressive end of a crowded field of AI-healthcare projections, most of which cluster between 40% and 45% CAGR depending on scope. The suspiciously precise CAGR (37.66%, not "approximately 38%") is a classic credibility signal in market research: false precision launders a wide confidence interval into an authoritative-sounding number.
Mechanistically, the bull case rests on a few real structural drivers: (1) LLM-based clinical documentation tools (Nuance DAX, Ambience, Suki) are already compressing physician admin time and have clear ROI narratives for CFOs; (2) AI-assisted radiology reads are moving from pilot to standard-of-care in high-volume settings; (3) pharma's adoption of generative AI in target identification and trial design is compressing pre-clinical timelines; (4) payer-side AI for prior authorization and fraud detection is scaling quietly but rapidly.
The bear case — which the report presumably buries — includes reimbursement uncertainty (CMS has been slow to create AI-specific billing codes), liability ambiguity that keeps risk-averse health systems in pilot purgatory, and the persistent interoperability problem that limits how much AI can actually ingest at inference time. Add the concentration risk: a significant chunk of current "market size" flows through a handful of EHR vendors and cloud hyperscalers, meaning the TAM (total addressable market) and the revenue of three companies overlap substantially.
Prior art on these forecasts is instructive. The AI-in-healthcare market was projected to hit ~$45B by 2026 in reports published circa 2019 — a figure that looks roughly on track, which gives the methodology some credibility, but those forecasts also assumed a linear regulatory environment that COVID and post-pandemic budget crunches disrupted significantly.
The falsifier to watch: if FDA AI/ML-based Software as a Medical Device (SaMD) clearances plateau, or if a high-profile diagnostic AI failure triggers congressional scrutiny, the adoption curve kinks well before 2035. Conversely, if CMS establishes reimbursement codes for AI-assisted procedures in the next 18 months, the forecast may actually be conservative in the near term.
Reality meter
Why this score?
Trust Layer Score basis
A detailed evidence breakdown is being added. For now, the score basis is the source list below and the reality meter above.
- 48 sources on file
- Avg trust 42/100
- Trust 40–95/100
Time horizon
Community read
Glossary
- CAGR
- Compound Annual Growth Rate; a measure of how much an investment or market grows on average each year over a multi-year period, accounting for the effect of compounding.
- LLM
- Large Language Model; an AI system trained on vast amounts of text data that can understand and generate human language, used here for tasks like clinical documentation.
- TAM
- Total Addressable Market; the total revenue opportunity available for a product or service if it captured 100% of a particular market.
- EHR
- Electronic Health Record; a digital system that stores and manages patient medical information, used by healthcare providers to document and access patient care data.
- SaMD
- Software as a Medical Device; software intended to diagnose, treat, or monitor medical conditions, which requires regulatory approval from agencies like the FDA.
- Interoperability
- The ability of different computer systems and software to work together and exchange data seamlessly, a key challenge in healthcare AI implementation.
What's your read?
Your read shapes future topic weighting.
Your vote feeds topic weights, community direction and future prioritisation. Open community direction
Sources
- Tier 3 AI in Healthcare Market Rises 37.66% Healthy CAGR by 2035
- Tier 3 Latest AI News, Developments, and Breakthroughs | 2026 | News
- Tier 3 The 2025 AI Index Report | Stanford HAI
- Tier 3 Artificial Intelligence News -- ScienceDaily
- Tier 3 AI Developments That Changed Vibrational Spectroscopy in 2025 | Spectroscopy Online
- Tier 3 AI breakthrough cuts energy use by 100x while boosting accuracy | ScienceDaily
- Tier 3 Reuters AI News | Latest Headlines and Developments | Reuters
- Tier 3 Inside the AI Index: 12 Takeaways from the 2026 Report
- Tier 1 Human scientists trounce the best AI agents on complex tasks
- Tier 3 Sony AI Announces Breakthrough Research in Real-World Artificial Intelligence and Robotics - Sony AI
- Tier 3 This new brain-like chip could slash AI energy use by 70% | ScienceDaily
- Tier 3 State AI Laws – Where Are They Now? // Cooley // Global Law Firm
- Tier 3 AI Regulation: The New Compliance Frontier | Insights | Holland & Knight
- Tier 3 The White House’s National Policy Framework for Artificial Intelligence: what it means and what comes next | Consumer Finance Monitor
- Tier 3 Trump Administration Releases National AI Policy Framework | Morrison Foerster
- Tier 3 What President Trump’s AI Executive Order 14365 Means For Employers | Law and the Workplace
- Tier 3 Manatt Health: Health AI Policy Tracker - Manatt, Phelps & Phillips, LLP
- Tier 3 Battle for AI Governance: White House’s Plan to Centralize AI Regulation and States’ Continuous Opposition
- Tier 3 AI Omnibus: Trilogue Underway…What to Expect as Negotiations Progress | Insights | Ropes & Gray LLP
- Tier 3 AI Regulation News Today 2025: Latest Updates on EU AI Act, US Rules & Global Impact - Prime News Mag
- Tier 3 AI regulation set to become US midterm battleground | Biometric Update
- Tier 3 Top Large Language Models of 2025 | Best LLMs Compared
- Tier 3 Large language model - Wikipedia
- Tier 1 [2604.27454] Exploring Applications of Transfer-State Large Language Models: Cognitive Profiling and Socratic AI Tutoring
- Tier 3 Top 50+ Large Language Models (LLMs) in 2026
- Tier 3 The Best Open-Source LLMs in 2026
- Tier 3 10 Best LLMs of April 2026: Performance, Pricing & Use Cases
- Tier 3 Emerging applications of large language models in ecology and conservation science
- Tier 3 From Elicitation to Evolution: A Literature-Grounded, AI-Assisted Framework for Requirements Quality, Traceability, and Non-Functional Requirement Management | IJCSE
- Tier 3 Labor market impacts of AI: A new measure and early ...
- Tier 3 Tracking the Impact of AI on the Labor Market - Yale Budget Lab
- Tier 3 AI and Jobs: Labor Market Impact Echoes Past Tech Transitions | Morgan Stanley
- Tier 3 The Jobs AI Is Likely to Boost—and Those It May Disrupt | Goldman Sachs
- Tier 3 How will Artificial Intelligence Affect Jobs 2026-2030 | Nexford University
- Tier 3 Young People Are Falling Behind, but Not Because of AI - The Atlantic
- Tier 3 AI is getting better at your job, but you have time to adjust, according to MIT | ZDNET
- Tier 3 New Data Challenges AI Job Loss Narrative | Robert H. Smith School of Business
- Tier 3 The impact of AI on the labour market | Management & Marketing | Springer Nature Link
- Tier 3 AI's impact on the job market is starting to show up in the data
- Tier 3 AI speeds up prior auth, coding while driving higher costs for health systems: PHTI report
- Tier 3 AI-enabled Medical Devices Market Size, Share | Forecast [2034]
- Tier 3 Journal of Medical Internet Research - Artificial Intelligence, Connected Care, and Enabling Digital Health Technologies in Rare Diseases With a Focus on Lysosomal Storage Disorders: Scoping Review
- Tier 3 Generative AI analyzes medical data faster than human research teams | ScienceDaily
- Tier 3 Rede Mater Dei de Saúde: Monitoring AI agents in the revenue cycle with Amazon Bedrock AgentCore | Artificial Intelligence
- Tier 3 Artificial Intelligence (AI) in Healthcare & Medical Field
- Tier 3 Here's how the data fed into medical AI can help — or hurt — health care | GBH
- Tier 3 Future of AI in Healthcare: Trends and Predictions for 2027 and Beyond
- Tier 3 2026 Conference
Optional Submit a prediction Optional: add your prediction on the core question if you like.
Prediction
Will the AI in healthcare market exceed $200 billion in annual revenue before the end of 2030?